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Progress Report  
Scientific Goals: This research is directed toward the development of a 
general method of tritium labeling of proteins and other molecules of biological 
interest with carefully controlled particle beams composed of T 14- and T2+ ions and 
fast T2 molecules. We have now tritiated over 10 different proteins and over 5 
different peptides and small molecules. After removing the readily exchangeable 
tritium, we have obtained specific activities of 300-900 Curie/mole with proteins 
and 20-40 Curie/mole with small molecules. The method labels all amino acid 
residues and has worked with every organic molecule which we have tried. 
Tritiation Apparatus: During the final year of this project we have 
developed a small mass spectrometer system to deliver an intense controlled energy 
beam of T3+ ions for the tritiation of proteins and other biomolecules. 
The experimental apparatus developed for this investigation consisted of an 
electron impact ion source, a magnetic mass sector, and ion-sample interaction 
region. A schematic of the ion beam apparatus is shown in Figure 1. 
Fig. 1. Schematic drawing of the ion beam apparatus mounted on the 
end flange of the tritiation chamber. 
Reactant ions were produced by controlled electron impact ionization of 
tritium gas. Electrons emitted by a directly heated filament were accelerated 
into the source chamber by a voltage variable from 0 to 60 volts. Two circular 
samarium-cobalt permanent magnets of 1.27 cm diameter were used to collimate the 
electron beam into a tight spiral as it passed through the ion source. Ions 
formed by electron impact were gently pushed through a relatively long (1 cm) 
distance to the ion source exit slit. As the ions traveled from their point of 
formation in the electron beam to the exit slit, the following ion-molecule 
reactions 
T2+ + T2 T3+ + T 
occurred to form 1 3+ ions. Both reactant Ti + and T2+ ions were accelerated to 
terminal velocities by voltages placed on pTates L? and L3. The relative 
positions of the various elements of this source are illustrated in figure 2. 
Fig, 2 
The electron impact ion source. Labeled 
are the filament F, the source chamber S, 
the repeller plate RP, the electron colli-
mating magnets M. and the beam focusing 
and acceleration plates LI, L2, and L3. 
After acceleration the ions drift into a 90° inflection field magnetic sector 
with a 3.61 cm radius of curvature. This magnetic sector was constructed of high 
field samarium-cobalt. The magnets were machined from 5.1 cm x 5.1 cm x 1.3 cm 
stock and them magnetized. A field strength on the order of 2000 gauss was 
obtained for a 2.5 cm gap a between the pole faces. 
Momentum analyzed ions were focused on the sample. The sample, in a cm 2 
 tray, was electrically insulated from the sample holder box which allows only 
focused ions from the magnetic sector to strike the sample. The tray was 
connected to ground through an ammeter which allowed measurement of ion current at 
the sample. 
We have thus been able to measure the reactivity of T 3+ as compared with T 2+ 
 and find that Tif is 40 times more reactive than 1 . ?-1- . Using pure 1 3 + ion beams we 
have been able to tritiate leupeptin to a level higher than previously obtained 
using un-mass analyzed ion beams. 
Biochemical Studies: The crude product of 3H- leupeptin had,a specific 
activity of 5 Ci/mole for Ti /. tritiation, and 230 Ci/mole for T3' tritiation. 
After tritiation, leupeptin wasworked up by lyophilization for three or four 
times and ion exchange chromatograph (Rio-Rex 70 column) to remove exchangeable 
tritium. The purity of the reaction products was checked by thin layer 
chromatography and autoradiography. We also measured trypsin inhibitory activity 
of leupeptin before and after tritiation. The concentration of leupeptin in 
solution was determined by Sakaguchi colorimetric method. After purification, the 
leupeptin obtained from T l+ tritiation had a specific activity of 87 Ci/mole. 
This is about four times higher than our previous best tritiation of leupeptin 
using the un-mass analyzed ion-beam labeling method. Samples with less than 8 mg 
gave slightly better results. The tritiated leupeptin was indistinguishable from 
pure native leupeptin. 
Experimental Problems: Relatively few tritiation experiments were carried 
out during this grant period since we were preoccupied with modifications on the 
apparatus itself. We had hoped to tritiate molecules such as 2-iodohenzoic acid 
and cinnamic acid by the ion beam labeling method to see if the tritium beam would 
replace the iodine atom or would add to the double bond of cinnamic acid. 
However, the tritiation apparatus is beginning to feel its age and we experienced 
numerous difficulties. One major problem was a continuing loss of the tritium 
into the traps probably due to seals in the valves which are beginning to fail. 
Thus we were able to carry out only a few experiments with leupeptin. 
Future Experiments: Even though the grant period has terminated, we plan a 
few last experiments with the tritiation apparatus before it is mothballed. Since 
we can no longer meter tritium accurately into the reaction chamber due to the 
valve problems, we are going to do up to seven tritiations using the full 5 Ci 
available in a vial of tritium gas. We are going to pack the reaction chamber 
with sample holders holding a total of 50-100 mg of sample. After introductionof 
the full 5 Ci of tritium into the reaction chamber, we will ion beam label one 
sample for 1 hr and then seal the chamber and allow gas labeling to take place on 
all the samples for a period of 1-2 weeks. One such experiment was started in the 
middle of December and was allowed to remain in the tritiation apparatus during 
the holidays. The sample is an experimental drug and the tritium labeled version 
will be utilized for metabolic studies. We expect to label up to six additional 
samples before our tritium supply is exhausted. 
Perspectives and Conclusions: The ion beam tritiation method has proved to 
he a convenient method to label any organic compound. After removing the readily 
exchangeable tritium, we have obtained specific activities of 300-900 Ci/mole with 
proteins and 20-90 Ci/mole with small molecules. With proteins, this method along 
with all other general tritium labeling techniques, suffers a major limitation. 
It is nearly impossible to remove all the exchangeable tritium which continues to 
leak from the protein whenever it is used. So far the only use that we have made 
of tritiated proteins has been as protease substrates where leakage of tritium is 
beneficial for assay purposes. In contrast, tritiation of small organicmolecules 
have proved to he much more useful. Although there are many methods for producing 
tritium labeled organic compounds, most require considerable effort and 
purification. The ion beam method is simple, convenient, and gives products which 
require very little purification. The specific activities obtained with the ion 
beam method are not as high as those obtained by direct chemical synthesis, but 
are quite reasonable for most biochemical studies. Thus, most of the 
investigators who approached us with samples for tritiation have given us small 
organic molecules which are sensitive and quite difficult to tritiate by any other 
method. We have tritiated 1-phenyl 1-aminomethylethene (S. May, Georgia Tech) for 
use in receptor binding studies and mevinolin (R. Abeles, Brandeis) which is a 
transition state inhibitor for HMG-CoA reductase. We have also supplied several 
investigators with samples of leupeptin. The samples which we plan to tritiate in 
the future are all small molecule drug candidates which are needed for metabolic 
studies. This is the area where the ion beam tritiation method has the most 
potential usefulness. In the future, if this technique is to going to be used 
more widely, it will be necessary to redesign the tritiation apparatus in order to 
simplify it. Our current apparatus was designed as a research tool and as such is 
very versatile, but contains too much plumbing to maintain. 
